Concepedia

Mohammad Bsharat

MB

6

Publications

1.1K

Citations

6

H-Index

2009

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

University of Toronto

Goethe University Frankfurt

Medizinische Hochschule Hannover

Eisai (United States)

Mohammad Bsharat is an author at Vertex Pharmaceuticals (United States) specializing in virology, medicine, and hepatitis.

Top concepts

Publications per year

2009–2021

6

Publications

6

Telaprevir for Previously Treated Chronic HCV Infection

John G. McHutchison, Michael P. Manns, Andrew J. Muir et al. · New England Journal of Medicine · 2010 · 719 citations · Full text

Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

Mark Sulkowski, Kenneth E. Sherman, Douglas T. Dieterich et al. · Annals of Internal Medicine · 2013 · 199 citations

Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial

Margaret Moline, Stephen Thein, Mohammad Bsharat et al. · The Journal of Prevention of Alzheimer s Disease · 2021 · 49 citations · Full text

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study

Jocelyn Y. Cheng, Gleb Filippov, Margaret Moline et al. · Journal of Sleep Research · 2020 · 48 citations · Full text

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

M.P. Manns, Andrew J. Muir, Nathalie Adda et al. · Journal of Hepatology · 2009 · 34 citations

, , +10

Rows per page

1–5 of 6